Explore
← New search
10 matching publication(s)
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
PMID 35870428 · EBioMedicine · 2022
L1
85/100
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.
PMID 37563310 · Nat Immunol · 2023
L1
93/100
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment.
PMID 37471455 · PLoS Comput Biol · 2023
L1
100/100
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
PMID 35028613 · Cell Rep Med · 2021
L1
75/100
Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases.⚑
PMID 34601390 · Comput Biol Med · 2021
L1
69/100
⚑
Differentially expressed genes reflect disease-induced rather than disease-causing changes in the transcriptome.
PMID 34561431 · Nat Commun · 2021
L1
100/100
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.⚑
PMID 32365491 · Cancers (Basel) · 2020
L1
35/100
⚑
Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.⚑
PMID 30503143 · Cell Stem Cell · 2018
L1
30/100
⚑
Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
PMID 29351318 · PLoS One · 2018
L1
97/100
CoINcIDE: A framework for discovery of patient subtypes across multiple datasets.
PMID 26961683 · Genome Med · 2016
L1
87/100